NCT00348725View on ClinicalTrials.gov

Acceptability of a Fixed Combination of Fenofibrate and Metformin

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

April 30, 2005

Conditions
Dyslipidemia/Glucose Metabolism Disorder
Interventions
DRUG

fenofibrate and metformin fixed combination (drug)

Trial Locations (25)

Unknown

Site 24, Anzin

Site 23, Bachant

Site 21, Bauné

Site 32, Bersée

Site 34, Briollay

Site 27, Denain

Site 28, Denain

Site 5, Le Temple-de-Bretagne

Site 29, Nantes

Site 2, Nantes

Site 8, Nantes

Site 9, Nantes

Site 1, Nort-sur-Erdre

Site 13, Parçay-les-Pins

Site 26, Quarouble

Site 7, Saint Aignan Le Grand

Site 30, Saint-Amand

Site 10, Saint-Étienne-de-Montluc

Site 4, Saint-Herblain

Site 11, Sautron

Site 17, Segré

Site 33, Thiant

Site 12, Thouars

Site 25, Vieux-Condé

Site 20, Vihiers

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00348725 - Acceptability of a Fixed Combination of Fenofibrate and Metformin | Biotech Hunter | Biotech Hunter